• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.27% Nasdaq Up 2.45%

    Transgenomic Inc. (TBIO)

    -NasdaqCM
    1.20 Up 0.08(7.14%) Aug 27, 4:00PM EDT
    |After Hours : 1.15 Down 0.05 (4.17%) Aug 27, 4:55PM EDT
    Add to Portfolio
    Prev Close:1.12
    Open:1.40
    Bid:1.12 x 200
    Ask:1.27 x 2000
    1y Target Est:8.00
    Beta:-1.52232
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:1.18 - 1.46
    52wk Range:1.04 - 4.39
    Volume:901,513
    Avg Vol (3m):917,228
    Market Cap:16.65M
    P/E (ttm):N/A
    EPS (ttm):-1.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TBIO

    Comparison

    Symbol% ChgMkt Cap
    TBIOUp 7.14%16.65M
    DGXUp 2.02%9.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.17
    Quarterly EPS Est (Sep-15) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transgenomic, Inc., a biotechnology company, engages in advancing personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and clinical and research services in the United... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback